| Serial Number | 88066252 |
| Word Mark | AESKUCARE |
| Filing Date | Monday, August 6, 2018 |
| Status | 653 - SUSPENSION LETTER - MAILED |
| Status Date | Monday, June 17, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Medical, chemical and biological test kits, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing for medical purposes, and test reagents, namely, genetic identity tests comprised of reagents for medical purposes; Antiserums for diagnostic purposes; Chemical reagents for medical diagnostic, medical or veterinary purposes; Medical or veterinary chemical test reagents for medical use; Chemical test reagents for medical use; Diagnostic preparations for medical or veterinary purposes; Diagnostic preparations for medical and veterinary purposes; Diagnostic preparations for medical, pharmaceutical or veterinary purposes; Diagnostic biomarker reagents for medical purposes; Diagnostic testing materials for medical use, namely, medical diagnosis test strips for blood analysis or bodily fluids analysis; Diagnostic reagents for medical use; Diagnostic substances for medical use; Immunoassay reagents for medical or medical diagnostic purposes; In vitro diagnostic preparations for medical use; Indicators for medical diagnosis, namely, diagnostic preparations for medical purposes; Medical diagnostic test strips for blood analysis or bodily fluids analysis; Medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic reagents; Preparations of microorganisms for medical or veterinary use; Preparations for detecting genetic predispositions for medical purposes; Preparations for detecting mutation in prion genes for medical purposes; Chemical reagents for use in analysis for veterinary purposes; Chemical reagents for analysis purposes for medical diagnostic, medical or veterinary purposes; Reagents for use in diagnostic tests comprised of veterinary diagnostic reagents; Diagnostic reagents for in-vitro laboratory use for medical purposes; Diagnostic reagents for in-vitro laboratory use for veterinary purposes; Diagnostic reagents for blood grouping for medical purposes; Medical diagnostic reagents for use with testing apparatus for testing of blood analysis or bodily fluids analysis for autoimmune diseases, neurological diseases or cancer for medical or medical diagnostic purposes; Diagnostic reagents for use in diagnostic tests and analyses for testing and analysis of blood or bodily fluids for autoimmune diseases, neurological diseases or cancer for medical purposes; Diagnostic reagents for use with testing apparatus for testing of blood or bodily fluids for autoimmune diseases, neurological diseases or cancer for medical diagnostic or veterinary purposes; Reactants for medical or veterinary diagnosis, namely, diagnostic reagents for medical and veterinary uses; Veterinary diagnostic reagents; Clinical medical reagents; Biological reagents for medical, medical diagnostic and veterinary purposes; Chemical reagents for medical, medical diagnostic and veterinary purposes; Chemical reagents for medical and veterinary purposes; Reagents for microbiological analysis, for medical or veterinary purposes; Genetic identity tests, consisting of reagents for medical purposes; Reagents and media for medical and veterinary diagnostic purposes; Reagents for medical use; Reagents for medical and veterinary genetic testing; Chemical preparations for use in DNA analysis for medical use; Chemical preparations for medical and medical diagnostic purposes, namely, for autoimmune diseases, neurological diseases or cancer; Blood for medical purposes, and blood plasma for medical diagnostic purposes; Biological preparations for medical, medical diagnostic and veterinary purposes for the treatment of autoimmune diseases, neurological diseases or cancer; Mixed biological preparations for medical and medical diagnostic purposes for the prevention and treatment of infectious diseases; Blood plasma; Blood components, namely, platelet rich blood plasma and stem cells for medical use; Blood protein fractions, namely, blood plasma fractions or bodily fluid fractions for medical diagnostic purposes and medical therapeutic purposes; Enzymes for medical, medical diagnostic and veterinary purposes; Enzyme preparations for medical and veterinary purposes; By-products of the processing of cereals for medical and medical diagnostic purposes; Nucleic acid sequences for medical diagnostic, medical and veterinary purposes |
| Translation of Words in Mark | The wording "AESKUCARE" has no meaning in a foreign language. |
| Goods and Services | Diagnostic preparations for clinical or medical laboratory use; Diagnostic reagents for clinical use; Diagnostic reagents for in-vitro clinical laboratory use |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, March 13, 2019 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, August 10, 2018 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Aeneas GmbH & Co. KG |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Wendelsheim 55234 DE |
| Event Date | Event Description |
| Wednesday, September 12, 2018 | NON-FINAL ACTION WRITTEN |
| Thursday, August 9, 2018 | NEW APPLICATION ENTERED |
| Friday, August 10, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, September 11, 2018 | ASSIGNED TO EXAMINER |
| Wednesday, September 12, 2018 | NON-FINAL ACTION E-MAILED |
| Wednesday, September 12, 2018 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, September 13, 2018 | NON-FINAL ACTION WRITTEN |
| Thursday, September 13, 2018 | NON-FINAL ACTION E-MAILED |
| Thursday, September 13, 2018 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, March 8, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, March 11, 2019 | ASSIGNED TO LIE |
| Wednesday, March 13, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, March 13, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Saturday, March 30, 2019 | SUSPENSION LETTER WRITTEN |
| Saturday, March 30, 2019 | LETTER OF SUSPENSION E-MAILED |
| Saturday, March 30, 2019 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Monday, October 7, 2019 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, October 7, 2019 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, October 9, 2019 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
| Wednesday, October 9, 2019 | SUSPENSION INQUIRY WRITTEN |
| Wednesday, October 9, 2019 | INQUIRY TO SUSPENSION E-MAILED |
| Wednesday, October 9, 2019 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
| Thursday, April 2, 2020 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Tuesday, April 7, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, April 7, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, April 10, 2020 | SUSPENSION LETTER WRITTEN |
| Friday, April 10, 2020 | LETTER OF SUSPENSION E-MAILED |
| Friday, April 10, 2020 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Tuesday, November 10, 2020 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
| Tuesday, November 24, 2020 | SUSPENSION INQUIRY WRITTEN |
| Tuesday, November 24, 2020 | INQUIRY TO SUSPENSION E-MAILED |
| Tuesday, November 24, 2020 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
| Thursday, April 22, 2021 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Wednesday, May 5, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, May 5, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, May 5, 2021 | SUSPENSION LETTER WRITTEN |
| Wednesday, May 5, 2021 | LETTER OF SUSPENSION E-MAILED |
| Wednesday, May 5, 2021 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Monday, November 8, 2021 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
| Monday, November 15, 2021 | ASSIGNED TO EXAMINER |
| Tuesday, November 16, 2021 | SUSPENSION INQUIRY WRITTEN |
| Tuesday, November 16, 2021 | INQUIRY TO SUSPENSION E-MAILED |
| Tuesday, November 16, 2021 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
| Wednesday, May 11, 2022 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Tuesday, May 24, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, May 24, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, May 24, 2022 | SUSPENSION LETTER WRITTEN |
| Tuesday, May 24, 2022 | LETTER OF SUSPENSION E-MAILED |
| Tuesday, May 24, 2022 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Monday, November 21, 2022 | SUSPENSION LETTER WRITTEN |
| Monday, November 21, 2022 | LETTER OF SUSPENSION E-MAILED |
| Monday, November 21, 2022 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Monday, May 22, 2023 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Monday, November 20, 2023 | SUSPENSION INQUIRY WRITTEN |
| Monday, November 20, 2023 | INQUIRY TO SUSPENSION E-MAILED |
| Monday, November 20, 2023 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
| Monday, February 19, 2024 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Monday, June 17, 2024 | LETTER OF SUSPENSION E-MAILED |
| Monday, June 17, 2024 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Monday, June 17, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, June 17, 2024 | SUSPENSION LETTER WRITTEN |
| Monday, June 17, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, June 17, 2024 | ASSIGNED TO LIE |